Japanese (NIKKEI) Pharma Industry Analysis
UpdatedJun 30, 2022
DataAggregated Company Financials
Companies40
- 7D1.4%
- 3M4.9%
- 1Y-3.8%
- YTD3.0%
The Pharma industry is up 1.4% in the last week, with Daiichi Sankyo Company up 3.8%. In contrast, the industry has lost 3.8% in the last 12 months. Earnings are forecast to grow by 11% annually.
Industry Valuation and Performance
Has the Japanese Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE |
|---|---|---|---|---|
| Fri, 01 Jul 2022 | JP¥35.7t | JP¥13.1t | JP¥1.5t | 18.1x |
| Sun, 29 May 2022 | JP¥34.5t | JP¥13.1t | JP¥1.5t | 17.8x |
| Tue, 26 Apr 2022 | JP¥35.1t | JP¥12.8t | JP¥1.5t | 20.6x |
| Thu, 24 Mar 2022 | JP¥35.0t | JP¥12.8t | JP¥1.5t | 20.7x |
| Sat, 19 Feb 2022 | JP¥34.1t | JP¥12.8t | JP¥1.5t | 18.4x |
| Mon, 17 Jan 2022 | JP¥33.5t | JP¥12.5t | JP¥1.6t | 17.4x |
| Wed, 15 Dec 2021 | JP¥34.0t | JP¥12.5t | JP¥1.6t | 18.3x |
| Fri, 12 Nov 2021 | JP¥35.8t | JP¥12.5t | JP¥1.6t | 18.2x |
| Sun, 10 Oct 2021 | JP¥36.0t | JP¥12.2t | JP¥1.5t | 17.9x |
| Tue, 07 Sep 2021 | JP¥38.6t | JP¥12.3t | JP¥1.5t | 18.4x |
| Thu, 05 Aug 2021 | JP¥34.1t | JP¥12.3t | JP¥1.5t | 17x |
| Sun, 09 May 2021 | JP¥35.1t | JP¥11.9t | JP¥1.4t | 18.2x |
| Wed, 10 Feb 2021 | JP¥39.2t | JP¥12.0t | JP¥1.3t | 22.1x |
| Tue, 03 Nov 2020 | JP¥33.1t | JP¥12.0t | JP¥1.2t | 22.2x |
| Fri, 07 Aug 2020 | JP¥36.9t | JP¥12.0t | JP¥1.3t | 22.3x |
| Thu, 30 Apr 2020 | JP¥35.1t | JP¥12.0t | JP¥1.2t | 21.5x |
| Sun, 02 Feb 2020 | JP¥36.6t | JP¥11.9t | JP¥1.2t | 21x |
| Wed, 06 Nov 2019 | JP¥33.6t | JP¥11.5t | JP¥1.2t | 19.9x |
| Sat, 10 Aug 2019 | JP¥30.2t | JP¥11.0t | JP¥1.2t | 19.5x |
Median PE Ratio
19.4x
Current Industry PE
- Investors are relatively neutral on the industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 26.3x.
- The industry is trading close to its 3-year average PS ratio of 2.9x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 7.7% per year over the last three years.
- Revenues for these companies have grown 6.1% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does Japanese Pharma compare with similar industries?
| JP Market | 0.26% | |
| Healthcare | 0.76% | |
| Pharma | 1.39% | |
| Pharma | 1.39% | |
Industry PEThere is insufficient data on the sub-industries of this industry.
Forecasted GrowthThere is insufficient data on the sub-industries of this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 4568 Daiichi Sankyo Company | JP¥3.44k | 3.8% +JP¥239.6b | 44.3% | PE98.4x | |
| 4502 Takeda Pharmaceutical | JP¥3.82k | 3.0% +JP¥171.3b | 1.7% | PE25.6x | |
| 4578 Otsuka Holdings | JP¥4.82k | 5.8% +JP¥144.3b | 5.4% | PE25.1x | |
| 4528 Ono Pharmaceutical | JP¥3.48k | 6.6% +JP¥105.5b | 39.3% | PE21.1x | |
| 4523 Eisai | JP¥5.73k | 2.9% +JP¥47.0b | -47.3% | PE34.2x |